Karuna Therapeutics, Inc.
Records under this name other than the patents Karuna Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Back to Karuna Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 16/950,203 | Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation Abandoned Abandoned May 14, 2024 | Abandoned | Abandoned May 14, 2024 | |
| 17/167,714 | Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation Abandoned Abandoned Dec 3, 2022 | Abandoned | Abandoned Dec 3, 2022 | |
| 17/310,735 | Compounds and Methods of Deuterated Xanomeline for Treating Neurological Disorders Abandoned Abandoned Dec 10, 2024 | Abandoned | Abandoned Dec 10, 2024 | |
| 17/663,760 | Methods for Treating Central Nervous System Disorders with Muscarinic Receptor Activation and Antipsychotics Abandoned Abandoned Jan 17, 2024 | Abandoned | Abandoned Jan 17, 2024 | |
| 18/454,177 | Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/853,947 | Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/138,334 | Substituted Tetrahydropyrrolo-Pyridinone Compounds and Their Use in Treating Medical Conditions Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/138,349 | Substituted Tetrahydropyrrolo-Pyridinone Compounds and Their Use in Treating Medical Conditions Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/138,393 | Substituted Dihydropyrrolo[3,4-d]pyrimidine Compounds and Their Use in Treating Medical Conditions Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/138,408 | Substituted Dihydropyrrolo[3,4-d]pyrimidine Compounds and Their Use in Treating Medical Conditions Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |